CBOA
RMD icon

Commonwealth Bank of Australia’s ResMed RMD Stock Holding History

Commonwealth Bank of Australia’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,978
Closed -$239K – 753
2019
Q2 		$239K Buy
1,978
+476
+32% +$52.7K ﹤0.01% 882
2019
Q1 		$154K Buy
1,502
+90
+6% +$9.29K ﹤0.01% 903
2018
Q4 		$159K Buy
1,412
+13
+0.9% +$1.39K ﹤0.01% 882
2018
Q3 		$160K Sell
1,399
-100
-7% -$11K ﹤0.01% 940
2018
Q2 		$153K Buy
1,499
+192
+15% +$19.4K ﹤0.01% 639
2018
Q1 		$127K Sell
1,307
-201
-13% -$19K ﹤0.01% 603
2017
Q4 		$126K Sell
1,508
-1,975,671
-100% -$163M ﹤0.01% 606
2017
Q3 		$152M Sell
1,977,179
-3,739
-0.2% -$286K 1.48% 17
2017
Q2 		$154M Sell
1,980,918
-590
-0% -$42.2K 1.55% 15
2017
Q1 		$143M Sell
1,981,508
-263
-0% -$18.2K 1.56% 14
2016
Q4 		$123M Sell
1,981,771
-5,393
-0.3% -$330K 1.5% 16
2016
Q3 		$129M Sell
1,987,164
-39,761
-2% -$2.65M 1.53% 20
2016
Q2 		$128M Sell
2,026,925
-8
-0% -$472 1.51% 21
2016
Q1 		$117M Sell
2,026,933
-33,987
-2% -$1.92M 1.43% 19
2015
Q4 		$111M Buy
2,060,920
+4,997
+0.2% +$282K 1.42% 19
2015
Q3 		$105M Buy
2,055,923
+178,318
+9% +$9.6M 1.34% 20
2015
Q2 		$106M Sell
1,877,605
-1,172,071
-38% -$74M 1.41% 19
2015
Q1 		$219M Sell
3,049,676
-758,273
-20% -$49.3M 2.96% 5
2014
Q4 		$213M Buy
3,807,949
+26,826
+0.7% +$1.4M 3.02% 6
2014
Q3 		$186M Buy
3,781,123
+197,750
+6% +$10.1M 2.41% 8
2014
Q2 		$181M Sell
3,583,373
-482,520
-12% -$23.9M 2.44% 6
2014
Q1 		$182M Sell
4,065,893
-354,943
-8% -$15.9M 1.16% 12
2013
Q4 		$208M Buy
4,420,836
+618,473
+16% +$31.3M 1.43% 6
2013
Q3 		$201M Sell
3,802,363
-180,882
-5% -$8.77M 1.46% 7
2013
Q2 		$180M Buy
+3,983,245
New +$189M 1.35% 8

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Commonwealth Bank of Australia's RMD Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of ResMed (RMD) in Q3 2019, closing a stake of 1,978 shares — an estimated $239K sold.

Commonwealth Bank of Australia first reported a position in RMD in Q2 2013 and held it in 25 quarters. The position peaked at $219M in Q1 2015. 528 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining ResMed position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 1,978 ResMed shares in Q3 2019, an estimated $239K.
  • Commonwealth Bank of Australia first reported a position in ResMed in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's ResMed position peaked at $219M in Q1 2015.
  • 528 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.